UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals ...

It could be the first new treatment for gonorrhea in 30 years. It could be the first new treatment for the infection in 30 ...

The appendix is thought to play a role in all of this by producing inflammatory proteins that trigger the body to produce ...

Parts of DaVita's network were locked down by the attack, and the company has not yet provided a timeline for recovery. DaVita works with over 700 U.S. hospitals providing kidney dialysis. In pharma ...

Female genital mutilation (FGM) affects almost all dimensions of the health of women and girls, according to a new study published today from the World Health Organization (WHO) together with the ...

The drug, called gepotidacin, works by preventing bacteria ... by the pharmaceutical company GSK and is sold under the name Blujepa. After reaching a historic low in 2009, cases of gonorrhea ...

A new type of antibiotic for urinary tract infections, called gepotidacin, may also work against the sexually transmitted infection. 5️⃣ Selling solo: After changes to commission practices ...

Gepotidacin, an antibiotic currently used to treat urinary tract infections, can also treat gonorrhoea, experts have found. It comes after researchers warned last month that gonorrhoea could ...

This could put the medication, called gepotidacin, on track to become the first new antibiotic for gonorrhea since the 1990s. “Gepotidacin is a novel oral antibacterial treatment with the potential to ...